Who are Standard BioTools Inc.'s main suppliers?

Standard BioTools Inc. (LAB) key suppliers include: Cytek Biosciences, Inc., Nautilus Biotechnology, Inc.. View the full supplier network at chainsifter.com/chain/LAB.

Who are Standard BioTools Inc.'s major customers?

Standard BioTools Inc. (LAB) key customers include: ILLUMINA, CAPITAL-RESOURCES. View the full customer network at chainsifter.com/chain/LAB.

What sector is Standard BioTools Inc. in?

Standard BioTools Inc. (LAB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Standard BioTools Inc. (LAB) Suppliers & Customers

2Suppliers

2Customers

3Debt Items

7Related Chains

Source-Backed Evidence Depth

Standard BioTools Inc. (LAB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships

1Distinct source URLs

5High confidence

0.823Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Standard BioTools Inc. Suppliers

Ticker	Name	Confidence	Evidence
CTKB	Cytek Biosciences, Inc.	72%	Reciprocal relationship from CTKB graph: Reciprocal relationship from LAB graph: Reciprocal relationship from CTKB graph: stics companies that design, manufacture and market flow cytometry instrument…
NAUT	Nautilus Biotechnology, Inc.	72%	Reciprocal relationship from NAUT graph: Reciprocal relationship from LAB graph: Reciprocal relationship from NAUT graph: r; (SCIEX); Becton, Dickinson and Company; Quanterix; and Illumina, Inc. (thr…

Standard BioTools Inc. Customers

Ticker	Name	Confidence	Evidence
ILLUMINA	ILLUMINA	92%	On January 30, 2026, the Company completed the sale of the Disposed Entities to Illumina pursuant to the Purchase Agreement.
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	Income tax (expense) benefit (11 ) (0 )% 119 — % Net loss from continuing operations (14,626 ) (69 )% (23,370 ) (115 )% Discontinued operations: Income (loss) from discontinued operations, net of tax…

Standard BioTools Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
LAB-DEBT	Debt stack $29.5M	90%	Market cache reports total debt of $29.5M.
LAB-DEBT-10603	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
LAB-DEBT-10602	Warrants outstanding: -232000	90%	xbrl warrant detail from xbrl 2025-12-31.

Standard BioTools Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Standard BioTools Inc..

Standard BioTools Inc. Ownership

Holder	Name	Confidence	Evidence
LAB-OWNER-CASDIN-CAPITAL-LLC	Casdin Capital, LLC	90%	13F overlay lists Casdin Capital, LLC as top holder; 155 tracked holders.

Standard BioTools Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BDX	Becton, Dickinson and Company	100.00	2
AMGN	Amgen Inc.	50.00	2
DHR	Danaher Corporation	50.00	2
WAT	Waters Corporation	50.00	2
AMGEN	AMGEN	50.00	2
NAUT	Nautilus Biotechnology, Inc.	42.84	1	['supplier']
CTKB	Cytek Biosciences, Inc.	36.29	1	['supplier']

Standard BioTools Inc. Supply Chain